Programmed Cell Death Protein-1 (PD1) Expression in the Microenvironment of Classical Hodgkin Lymphoma Is Similar Between Favorable and Adverse Outcome and Does Not Enrich Over Serial Relapses With Conventional Chemotherapy

Haematologica - Italy
doi 10.3324/haematol.2018.204818
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Ferrata Storti Foundation (Haematologica)

Related search

HIV Status Does Not Influence Outcome in Patients With Classical Hodgkin Lymphoma Treated With Chemotherapy Using Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine in the Highly Active Antiretroviral Therapy Era

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2012English

Classical Hodgkin Lymphoma With Reduced 2m/MHC Class I Expression Is Associated With Inferior Outcome Independent of 9p24.1 Status

Cancer immunology research
Cancer ResearchImmunology
2016English

More Chemotherapy Does Not Obviate the Need for Radiation Therapy (RT): Treatment for Early-Stage Favorable Hodgkin Lymphoma According to the HD10 Trial Compared With Chemotherapy Alone

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

Human Germinal Center-Associated Lymphoma Protein Expression Is Associated With Improved Failure-Free Survival in Brazilian Patients With Classical Hodgkin Lymphoma

Leukemia and Lymphoma
Cancer ResearchOncologyHematology
2009English

Increased Programmed Death-1 Expression on CD4+ T Cells in Cutaneous T-Cell Lymphoma

Archives of Dermatology
2010English

Catching Up With Solid Tumor Oncology: What Is the Evidence for a Prognostic Role of Programmed Cell Death-Ligand 1/Programmed Cell Death-1 Expression in B-Cell Lymphomas?

Haematologica
Hematology
2016English

Expression of PD-1 and PD-L1 Increase in Consecutive Biopsies in Patients With Classical Hodgkin Lymphoma

PLoS ONE
Multidisciplinary
2018English

Higher Programmed Cell Death 1 Ligand 1 (PD-L1) mRNA Level in Clear Cell Renal Cell Carcinomas Is Associated With a Favorable Outcome Due to the Active Immune Responses in Tumor Tissues

Oncotarget
Oncology
2016English

Programmed Death Ligand 1 in Non-Clear Cell Renal Cell Carcinoma and Correlation With Tumor Microenvironment and Prognostic Factors

Medical Journal of Islamic World Academy of Sciences
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy